Najat C. Daw

8.1k total citations
154 papers, 4.7k citations indexed

About

Najat C. Daw is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Najat C. Daw has authored 154 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Pulmonary and Respiratory Medicine, 62 papers in Molecular Biology and 33 papers in Oncology. Recurrent topics in Najat C. Daw's work include Sarcoma Diagnosis and Treatment (67 papers), Renal and related cancers (25 papers) and Neuroblastoma Research and Treatments (24 papers). Najat C. Daw is often cited by papers focused on Sarcoma Diagnosis and Treatment (67 papers), Renal and related cancers (25 papers) and Neuroblastoma Research and Treatments (24 papers). Najat C. Daw collaborates with scholars based in United States, Canada and Chile. Najat C. Daw's co-authors include Catherine A. Billups, Bhaskar N. Rao, M. Beth McCarville, Jianrong Wu, Carlos Rodríguez‐Galindo, Fariba Navid, Victor M. Santana, Jesse J. Jenkins, Michael D. Neel and Sue C. Kaste and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Najat C. Daw

151 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Najat C. Daw United States	40	2.7k	1.4k	1.2k	843	724	154	4.7k
Catherine A. Billups United States	48	2.5k 0.9×	2.0k 1.4×	1.8k 1.4×	643 0.8×	856 1.2×	165	6.0k
Uta Dirksen Germany	38	3.6k 1.3×	1.5k 1.0×	1.5k 1.2×	685 0.8×	976 1.3×	190	5.8k
Richard B. Womer United States	39	3.8k 1.4×	1.2k 0.8×	1.6k 1.3×	1.2k 1.4×	1.1k 1.6×	111	6.1k
Salvatore Lo Vullo Italy	35	2.4k 0.9×	785 0.5×	2.3k 1.9×	1.2k 1.4×	1.4k 2.0×	79	4.9k
Christophe Bergeron France	44	2.5k 0.9×	2.1k 1.5×	1.3k 1.0×	387 0.5×	705 1.0×	174	5.4k
Leonard H. Wexler United States	48	4.2k 1.5×	1.3k 0.9×	2.2k 1.8×	1.3k 1.6×	1.1k 1.5×	159	7.6k
Daniel Orbach France	41	3.4k 1.3×	1.2k 0.8×	1.8k 1.5×	1.3k 1.5×	1.9k 2.6×	317	6.3k
H. Jürgens Germany	40	3.4k 1.2×	851 0.6×	1.1k 0.9×	1.2k 1.5×	1.2k 1.6×	138	5.4k
A. Zoubek Austria	35	4.7k 1.7×	1.6k 1.1×	1.6k 1.3×	1.6k 1.9×	1.2k 1.7×	101	6.6k
David Pérol France	37	3.4k 1.3×	1.1k 0.8×	2.2k 1.8×	511 0.6×	1.0k 1.4×	256	6.1k

Countries citing papers authored by Najat C. Daw

Since Specialization

Citations

This map shows the geographic impact of Najat C. Daw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Najat C. Daw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Najat C. Daw more than expected).

Fields of papers citing papers by Najat C. Daw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Najat C. Daw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Najat C. Daw. The network helps show where Najat C. Daw may publish in the future.

Co-authorship network of co-authors of Najat C. Daw

This figure shows the co-authorship network connecting the top 25 collaborators of Najat C. Daw. A scholar is included among the top collaborators of Najat C. Daw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Najat C. Daw. Najat C. Daw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armstrong, Amy E., Najat C. Daw, Lindsay A. Renfro, et al.. (2025). Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies. Cancer. 131(2). e35713–e35713. 2 indexed citations

Bronk, Julianna, Mary Frances McAleer, Susan L. McGovern, et al.. (2024). Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study. Radiotherapy and Oncology. 195. 110270–110270. 2 indexed citations

Chen, Yan, Yutaka Yasui, Rachel Phelan, et al.. (2024). Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). Pediatric Blood & Cancer. 71(10). e31189–e31189. 2 indexed citations

Meyers, Paul A., Noah Federman, Najat C. Daw, et al.. (2024). Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma. Journal of Clinical Oncology. 42(31). 3725–3734. 13 indexed citations

Benedetti, Daniel J., Lindsay A. Renfro, Najat C. Daw, et al.. (2024). Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. Cancer. 130(13). 2361–2371. 2 indexed citations

Jeyabal, Prince, Anchit Bhagat, Fei Wang, et al.. (2023). Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. Clinical Cancer Research. 29(21). 4430–4440. 6 indexed citations

Truong, Danh D., Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, et al.. (2023). Abstract 1196: The epigenetic impact and therapeutic opportunity of AR-directed therapy for DSRCT. Cancer Research. 83(7_Supplement). 1196–1196. 1 indexed citations

Walz, Amy L., Mariana Maschietto, Brian D. Crompton, et al.. (2023). Tumor biology, biomarkers, and liquid biopsy in pediatric renal tumors. Pediatric Blood & Cancer. 70(S2). e30130–e30130. 9 indexed citations

Oosterom, Natanja, Saskia L. Gooskens, Lindsay A. Renfro, et al.. (2023). Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy. Journal of Clinical Oncology. 41(26). 4247–4256. 1 indexed citations

10.

Geller, James I., Nicholas G. Cost, Yueh‐Yun Chi, et al.. (2020). A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study. Cancer. 126(23). 5156–5164. 13 indexed citations

11.

Tarek, Nidale, Rabih Said, Clark R. Andersen, et al.. (2020). Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. Cancers. 12(10). 2927–2927. 12 indexed citations

12.

Subbiah, Vivek, Pete Anderson, Kalevi Kairemo, et al.. (2019). Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clinical Cancer Research. 25(13). 3802–3810. 32 indexed citations

13.

Daw, Najat C., Yueh‐Yun Chi, Yeonil Kim, et al.. (2019). Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study. European Journal of Cancer. 118. 58–66. 23 indexed citations

14.

Livingston, J. Andrew, Wei‐Lien Wang, Jen-Wei Tsai, et al.. (2018). Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients. Molecular Cancer Therapeutics. 17(6). 1315–1323. 15 indexed citations

15.

Subbiah, Vivek, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, et al.. (2018). Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. Clinical Cancer Research. 24(19). 4865–4873. 61 indexed citations

16.

Turner, David C., Fariba Navid, Najat C. Daw, et al.. (2014). Population Pharmacokinetics of Bevacizumab in Children with Osteosarcoma: Implications for Dosing. Clinical Cancer Research. 20(10). 2783–2792. 40 indexed citations

17.

Juergens, Heribert, Najat C. Daw, Birgit Geoerger, et al.. (2011). Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma. Journal of Clinical Oncology. 29(34). 4534–4540. 165 indexed citations

18.

Debelenko, Larisa V., Susana C. Raimondi, Najat C. Daw, et al.. (2010). Renal cell carcinoma with novel VCL–ALK fusion: new representative of ALK-associated tumor spectrum. Modern Pathology. 24(3). 430–442. 176 indexed citations

19.

Furman, Wayne L., Fariba Navid, Najat C. Daw, et al.. (2009). Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors. Journal of Clinical Oncology. 27(27). 4599–4604. 42 indexed citations

20.

Hayes‐Jordan, Andrea, Najat C. Daw, Wayne L. Furman, Fredric A. Hoffer, & Stephen J. Shochat. (2004). Tumor recurrence at thoracostomy tube insertion sites: A report of two pediatric cases. Journal of Pediatric Surgery. 39(10). 1565–1567. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact